Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Dermatologists prefer minoxidil for mild female hair loss and a combination of PRP and minoxidil for severe cases, with a need for universal treatment guidelines.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Imiquimod 5% cream reduced equine sarcoids in most cases.

Women pay more for the same 5% minoxidil foam than men, but prices for liquid solutions are similar.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Zinc supplements improved hair and skin conditions in two patients.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

Topical melatonin and brushing did not affect hair regrowth in Siberian Huskies.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Eating a balanced diet with vitamins, micronutrients, and antioxidants is important for hair health and can help with hair loss.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.

Low iron levels are linked to hair loss in women.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Accurate gender and sex assessment in dermatology is essential for respectful and precise patient care.

All immigrant workers in the study had skin problems, with fungal nail infections, athlete's foot, and acne or folliculitis being most common, affecting their quality of life, yet they didn't seek medical help.

Men who are perfectionists feel more upset about baldness, partly due to aging anxiety.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.